Table 1. Baseline Characteristics of MTX-Naive and MTX-User Patients.

From: Impact of the 2018 Japan Floods on Methotrexate and Antirheumatic Drug Prescriptions: A Longitudinal Analysis of the Japanese National Database

MTX-naive MTX-user
Victims Non-victims ASD Victims Non-victims ASD
All participants, n 31,006 4,942,395 110 14,798
Age classification, n (%) 20-44 6,668 (21.5%) 1,710,176 (34.6%) 0.295 a (a) 1,067 (7.2%) NC
45-64 8,103 (26.1%) 1,451,712 (29.4%) 0.074 b (b) 4,949 (33.4%) NC
65+ 16,235 (52.4%) 1,780,507 (36.0%) 0.335 74 (67.3%) 8,782 (59.3%) NC
Sex, n (%) Male 13,528 (43.6%) 2,298,159 (46.5%) 0.058 31 (28.2%) 3,948 (26.7%) 0.034
Female 17,478 (56.4%) 2,644,236 (53.5%) 0.058 79 (71.8%) 10,850 (73.3%) 0.034
Table 2. Incidence of New Prescription of MTX and Other Antirheumatic Drugs after the Disaster.

From: Impact of the 2018 Japan Floods on Methotrexate and Antirheumatic Drug Prescriptions: A Longitudinal Analysis of the Japanese National Database

Victims Non-victims p-Value
MTX, n (%) 54 (0.17%) 3,811 (0.08%) p < 0.001
bDMARDs, n (%) a (a) 414 (2.8%) p = 0.093
csDMARDs. n (%) a (a) 1,074 (7.3%) p = 0.467
Glucocorticoid, n (%) 13 (11.8%) 1,547 (10,5%) p = 0.641
Any of the antirheumatic drugs 23 (20.9%) 2,627 (17.8%) p = 0.388
PAGE TOP